Literature DB >> 7798217

A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression.

C J Fiol1, J S Williams, C H Chou, Q M Wang, P J Roach, O M Andrisani.   

Abstract

The cAMP-dependent protein kinase (PKA) phosphorylates CREB327/341 at a single serine residue, Ser119/133, respectively. Phosphorylation at this site creates the sequence motif SXXXS(P), a consensus site of the glycogen synthase kinase-3 (GSK-3) enzyme (Fiol, C.J., Mahrenholz, A.M., Wang, Y., Roeske, R.W., and Roach, P.J. (1987) J. Biol. Chem. 262, 14042-14048). We examined the phosphorylation of CREB at the SXXXS(P) consensus site and its role in CREB transactivation to cAMP induction. Neither isoform of the GSK-3 enzyme (GSK-3 alpha or beta) utilizes CREB as its substrate unless CREB is already phosphorylated at Ser119/133. A 13-amino acid peptide containing the sequence surrounding Ser119/133 was phosphorylated by GSK-3, at Ser115/129, only after the primary phosphorylation of the peptide by PKA (at Ser119/133), suggesting that Ser115/129 is a GSK-3 phosphoacceptor site. Mutant CREB327/341 proteins containing Ser-->Ala substitutions confirmed Ser115/129 as the only GSK-3 phosphorylation site. Transfection assays of wild type and mutant Gal4-CREB fusion proteins in PC12 cells demonstrated that Ser-->Ala substitution of residue 129 of CREB341 impairs the transcriptional response to cAMP induction. Analogous mutation in CREB327 results in 70% decrease in its transactivation response to cAMP. In undifferentiated F9 cells, which are refractory to cAMP induction, transfected GSK-3 beta kinase induces a 60-fold increase in cyclic AMP response element-dependent transcription, mediated via the endogenous CREB protein. We propose that the hierarchical phosphorylation at the PKA and GSK-3 sites of CREB are essential for cAMP control of CREB.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7798217

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

1.  A second calcineurin binding site on the NFAT regulatory domain.

Authors:  S Park; M Uesugi; G L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Transcriptional regulation by cAMP in the heart.

Authors:  F U Müller; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 3.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

4.  Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action.

Authors:  H Eldar-Finkelman; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

5.  Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.

Authors:  M Li; X Wang; M K Meintzer; T Laessig; M J Birnbaum; K A Heidenreich
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

6.  Ca2+-dependent block of CREB-CBP transcription by repressor DREAM.

Authors:  Fran Ledo; Leonor Kremer; Britt Mellström; Jose R Naranjo
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

7.  The Scaffold Protein Axin Promotes Signaling Specificity within the Wnt Pathway by Suppressing Competing Kinase Reactions.

Authors:  Maire Gavagan; Erin Fagnan; Elizabeth B Speltz; Jesse G Zalatan
Journal:  Cell Syst       Date:  2020-06-17       Impact factor: 10.304

8.  Glycogen synthase kinase-3 represses cyclic AMP response element-binding protein (CREB)-targeted immediate early genes in quiescent cells.

Authors:  John W Tullai; Jie Chen; Michael E Schaffer; Eliza Kamenetsky; Simon Kasif; Geoffrey M Cooper
Journal:  J Biol Chem       Date:  2007-02-03       Impact factor: 5.157

Review 9.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

10.  A cAMP and CREB-mediated feed-forward mechanism regulates GSK3β in polycystic kidney disease.

Authors:  Vijayakumar R Kakade; Shixin Tao; Madhumitha Rajagopal; Xia Zhou; Xiaogang Li; Alan S L Yu; James P Calvet; Pankaj Pandey; Reena Rao
Journal:  J Mol Cell Biol       Date:  2016-05-04       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.